NAMPT Is A Novel Inhibitor of Vascular Calcification in Chronic Kidney Disease
Our study unveils that NAMPT could serve as a novel endogenous inhibitor of vascular calcification via modulation of SIRT1-mediated deacetylation of NICD.
Authors
- Li Li (ORCID: https://orcid.org/0009-0009-8857-1900)
- Yining Li (ORCID: https://orcid.org/0009-0003-7613-2659)
- Liyun Feng (ORCID: https://orcid.org/0009-0009-9025-9254)
- Hao Liu (ORCID: https://orcid.org/0000-0001-7175-9442)
- Yuanzhi Ye (ORCID: https://orcid.org/0009-0003-9455-7597)
- Qingchun Liang (ORCID: https://orcid.org/0000-0001-9318-2357)
- Lihe Lu (ORCID: https://orcid.org/0000-0003-4518-3325)
- Jianyun Yan (ORCID: https://orcid.org/0000-0002-6962-1169)
- Zirong Lan (ORCID: https://orcid.org/0009-0004-7086-8996)
- Xiuli Zhang (ORCID: https://orcid.org/0000-0002-2478-356X)
- Xiaoyu Liu (ORCID: https://orcid.org/0009-0004-3994-3265)
- Jiahui Zhu
- Qianqian Dong (ORCID: https://orcid.org/0009-0001-7001-7583)
- An Chen (ORCID: https://orcid.org/0000-0001-7607-977X)
Institutions
- Sun Yat-sen University (CN)
- Jinan University (CN)
- Third Affiliated Hospital of Southern Medical University (CN)
- Nanfang Hospital (CN)
- Zhujiang Hospital (CN)
- Guangdong Provincial Academy of Environmental Science (CN)
- Southern Medical University (CN)
Publication Details
- Journal
- Arteriosclerosis Thrombosis and Vascular Biology
- Published
- 2025-09-04
- DOI
- https://doi.org/10.1161/atvbaha.125.322549
- Citations
- 1
- Primary Topic
- Parathyroid Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.43